Dr. Kinnari Arte, currently a scientist with AstraZeneca, has successfully defended her Ph.D. Thesis. Kinnari studied spray freeze drying of mRNA lipid nanoparticle vaccines: ‘Understanding the Impact of Spray Freeze Drying on RNA/LNP Formulations’ as a CPPR student under the mentorship of Dr. Qi (Tony) Zhou, CPPR Assistant Site Director at Purdue University. Congratulations on this milestone achievement!
Dr. Qi (Tony) Zhou has been approved by the Purdue Board of Trustees as a Full Professor of Industrial and Molecular Pharmaceutics. Tony is the Assistant Site Director for CPPR at Purdue. We congratulate him on this well-deserved accomplishment!
Dr. Xiuling Lu, CPPR faculty and Professor of Pharmaceutics at UConn School of Pharmacy, has been inducted into the CT Academy of Science and Engineering (CASE). Dr. Lu is working to develop new drug delivery systems and improving manufacturing processes. She joins CPPR faculty, Dr. Bodhi Chaudhuri, who was inducted in 2024. Read more here: UConn’s Influence on CASE: Research Contributions, Policy Impact, and Future Trends in Connecticut – Forward Pathway
AbbVie joins Alexion, Alkermes, Astrazeneca, ATS Scientific Products, Boehringer-Ingelhiem, Gilead, Glaxosmithkline, Lilly, Otsuka, Roquette, and Sanofi on the CPPR Industrial Advisory Board. We look forward to AbbVie’s participation in our quest to advance pharmaceutical processing. The funds that AbbVie has committed to CPPR research are pooled with those of the other member companies. The funds support rigorous academic research into industrially relevant pharmaceutical processing research at the CPPR academic sites, with mentorship from representatives from CPPR companies.
Dr. Raman Bahal, CPPR Faculty, is the 2025 recipient of the UConn School of Pharmacy Faculty Research Advising Award. He is a world leader in developing novel technologies at the nucleic acid chemistry and biology interface to target genomic DNA and RNA for treating diseases that are unavailable elsewhere. Over the past seven years, he has mentored 24 Pharm.D. and undergraduate students, demonstrating his commitment to shaping the next generation of pharmaceutical professionals.
CPPR Student, Saurav Adhikari, from the lab of Professor Na Li was named the Steve Nail Emerging Researcher at the CPPR Scientific Conference held at Purdue University in November 2024. Steve was on-hand to present the award.
CPPR Faculty, Dr. Na Li and Dr. Bodhi Chaudhuri from University of Connecticut, and Dr. Li’s student, DaHye Yang, describe how the particle drifting effect leads to increased drug absorption rates in a recent publication in Molecular Pharmaceutics. Read more about the mechanisms of this fascinating phenomenon at https://doi.org/10.1021/acs.molpharmaceut.4c00751.
CPPR Faculty, Dr. Na Li from University of Connecticut, and her student, Akshay Narula, published their findings on the growth mechanisms of amorphous nanoparticles in the Journal of Pharmaceutical Sciences. Read more at https://doi.org/10.1016/j.xphs.2024.08.017.
AIChE ‘s Fellow is the organization’s highest membership grade. AIChE fellow candidates are nominated by their peers and must have significant professional accomplishment, exceptional contribution in the field of chemical engineering, and those who have demonstrated long-term excellence in the profession. New AIChE Fellows will be recognized at the upcoming AIChE Annual Meeting, Oct. 27-31, in San Diego, California
CPPR Faculty, Raj Suryanarayanan from University of Minnesota, and his co-authors, Jinghan Li, Bhushan Munjal, Chaowang Zeng, published their findings on the dual functionality of poloxamer 188 in freeze-dried protein formulations in Molecular Pharmaceutics. Read more at https://doi.org/10.1021/acs.molpharmaceut.4c00108. 